Effect of Arjun on cardiac function in Coronary artery disease

Effect of Terminalia arjuna (add-on medication) on cardiac function of patients of Coronary artery disease-A Randomized controlled clinical study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/022034

Enrollment

Registered

2019-11-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: I00-I99- Diseases of the circulatory system

Interventions

Intervention1: Arjun(Terminalia arjuna): Terminalia arjuna Stem bark ghana 500 mg(in capsule form) 8 hourly with water for 90 days as an adjuvant with conventional treatment Control Intervention1: Con

Eligibility

Inclusion criteria

Inclusion criteria: 1 Diagnosed patient of coronary artery disease by any of the following investigations 2 ECG (ST elevation/depression, T-wave inversion) 3 Transthoracic echocardiography(Regional wall motion abnormalities â?? wall motion score index 1.1-1.9) 4 Treadmill exercise test(TMT) 5 Stable Patients of CAD after 15 days of its onset 6 Stable Patients of CAD after one month of coronary bypass surgery, or coronary stenting.

Exclusion criteria

Exclusion criteria: 1 Patients of coronary bypass surgery, or coronary stenting of the period 2 Patients of Arrhythmia 3 Patients of severe heart failure 4 Patients with any type of serious infection. 5 Patients with Renal failure or CKD 6 Patients with Portal hypertension 7 Critically ill patient 8 Patient with Type I Diabetes mellitus or uncontrolled Type II Diabetes mellitus. 9 Patients with severe musculoskeletal disorders 10 Patients with COPD

Design outcomes

Primary

Measure	Time frame
1 To evaluate the effect of Terminalia arjuna on Ejection fraction. 2 To evaluate the effect of Terminalia arjuna on cardiac function by 6MWT (Six minute walk test). Timepoint: 1 To evaluate the effect of Terminalia arjuna on Ejection fraction. 2 To evaluate the effect of Terminalia arjuna on cardiac function by 6MWT (Six minute walk test).	—

Secondary

Measure	Time frame
1 To evaluate the effect of Terminalia arjuna in vascular inflammatory marker (hsCRP). 2 To evaluate the effect of Terminalia arjuna on lipid parameters. Timepoint: 90th day	—

Countries

India

Contacts

Public ContactDr Vaishali Kuchewar

MGACH&RC DMIMS (DU) Sawangi Wardha

vkuchewar@gmail.com9420998747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026